OCS DCD Heart + CAP Continued Follow-Up (NCT05741723)
OCS DCD Heart + CAP Continued Follow-Up Post-Approval Study
🩺 Plain-English Summary (8th-Grade Level)
The objective of this post-approval study is to evaluate long-term outcomes of patients enrolled in the OCS DCD Heart and OCS DCD Heart CAP studies.
Who can join: To join this study, participants generally need to meet the listed inclusion criteria (1 items) and avoid the listed exclusions (0 items).
Location: University of California San Diago — La Jolla, California
Age range: 18 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistCheck every box below. If you can check all of them, you may meet the study's basic screening requirements (final eligibility is confirmed by the site team).
🔍 Extracted verbatim from the official NIH eligibility criteria. Always confirm with the study coordinator.
📍 All Participating Trial Locations (20 Sites)
- University of California San Diago — La Jolla, California
- Stanford University — Palo Alto, California
- Yale New Haven Hospital — New Haven, Connecticut
- Mayo Clinic Florida — Jacksonville, Florida
- AdventHealth Orlando — Orlando, Florida
- Emory University Hospital — Atlanta, Georgia
- Northwestern Medicine — Chicago, Illinois
- St. Vincent Cardiovascular Research Institute — Indianapolis, Indiana
- Tufts Medical Center — Boston, Massachusetts
- Massachusetts General Hospital — Boston, Massachusetts
- Minneapolis Heart Institute — Minneapolis, Minnesota
- University of Minnesota — Minneapolis, Minnesota
- University of Nebraska Medical Center — Omaha, Nebraska
- Nyph/Cumc — New York, New York
- Montefiore — The Bronx, New York
- Duke University — Durham, North Carolina
- Vanderbilt Medical Center — Nashville, Tennessee
- Sentara — Norfolk, Virginia
- University of Wisconsin — Madison, Wisconsin
- Froedtert & the Medical College of Wisconsin — Milwaukee, Wisconsin
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Heart Transplant
- XVIVO Heart Box (XHB) With Supplemented XVIVO Heart Solution (SXHS) Continued Access Protocol (CAP) — La Jolla, California
- US National OCS Heart Perfusion (OHP) Registry — Phoenix, Arizona
- Randomized Trial of SGLT2i in Heart Transplant Recipients — Palo Alto, California
- Belatacept in Heart Transplantation — Los Angeles, California
- Non-invasive Prediction of EArly Cardiac rEjection — Little Rock, Arkansas
Explore by condition: All Heart Transplant clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Review the official NIH record below to find the coordinating site.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.